CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- Open-market buys, last 90 days
- $291,587
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$291,587. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-01-02 | KUMAR AMIT Director | Other acquisition | +10,471 | $0.19 | $2K | 93,004 |
| 2014-01-02 | JOHNSON BRUCE F Director | Other acquisition | +10,471 | $0.19 | $2K | 6,516,428 |
| 2014-01-02 | BERMAN ROBERT ANDREW President and CEO | Other acquisition | +5,236 | $0.19 | $1K | 16,902 |
| 2013-11-08 | KUMAR AMIT Director | Grant or award · Employee Stock Options (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2013-11-08 | Roop John H. Sr. Vice President-Engineering | Grant or award · Employee Stock Options (Right to Buy) | +500,000 | 500,000 | ||
| 2013-11-08 | HERMS HENRY P VP Finance and CFO | Grant or award · Employee Stock Options (Right to Buy) | +550,000 | 550,000 | ||
| 2013-11-08 | BERMAN ROBERT ANDREW President and CEO | Grant or award · Employee Stock Options (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2013-11-08 | Titterton Lewis H jr Director | Grant or award · Employee Stock Options (Right to Buy) | +3,000,000 | 3,000,000 | ||
| 2013-09-09 | HERMS HENRY P VP Finance and CFO | Sale | −2,500 | $0.22 | $538 | 513,125 |
| 2013-09-09 | HERMS HENRY P VP Finance and CFO | Sale | −7,500 | $0.21 | $2K | 505,625 |
| 2013-09-09 | HERMS HENRY P VP Finance and CFO | Sale | −27,500 | $0.21 | $6K | 478,125 |
| 2013-09-06 | HERMS HENRY P VP Finance and CFO | Sale | −5,000 | $0.21 | $1K | 515,625 |
| 2013-09-05 | HERMS HENRY P VP Finance and CFO | Sale | −3,850 | $0.22 | $837 | 566,725 |
| 2013-09-05 | HERMS HENRY P VP Finance and CFO | Sale | −12,500 | $0.21 | $3K | 554,225 |
| 2013-09-05 | HERMS HENRY P VP Finance and CFO | Sale | −10,000 | $0.21 | $2K | 544,225 |
| 2013-09-05 | HERMS HENRY P VP Finance and CFO | Sale | −9,100 | $0.21 | $2K | 535,125 |
| 2013-09-05 | HERMS HENRY P VP Finance and CFO | Sale | −5,000 | $0.20 | $1K | 530,125 |
| 2013-09-05 | HERMS HENRY P VP Finance and CFO | Sale | −9,500 | $0.20 | $2K | 520,625 |
| 2013-07-15 | Titterton Lewis H jr Director | Option exercise | +1,400,000 | $0.16 | $224K | 9,794,025 |
| 2013-07-15 | Titterton Lewis H jr Director | Option exercise · Common Stock Purchase Warrants (Right to Buy) | −1,400,000 | $0.18 | $250K | 0 |
Page 33 of 34 · 669 trades